Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Filings indexed 3,374 across all filing types
Latest filing 2023-03-24 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
Annual Report 2022
Regulatory Filings
2023-03-24 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022
Annual Report Classification · 100% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022' and explicitly states it contains the full text of the 2022 Annual Report of Yankuang Energy Group Company Limited. It includes detailed chapters such as Definitions, Company Information, Chairman's Statement, Board of Directors' Report, Corporate Governance, Environmental & Social Responsibilities, Significant Events, Changes in Shares and Shareholders, Corporate Bonds, Independent Auditor's Report, and Consolidated Financial Statements. The document length is 15,000 characters, indicating a comprehensive report rather than a brief announcement. The presence of audited financial statements and detailed company information confirms this is the official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K).
2023-03-24 English
PROPOSED ELECTION OF DIRECTORS OF THE NINTH SESSION OF THE BOARD AND PROPOSED ELECTION OF SUPERVISORS OF THE NINTH SESSION OF THE SUPERVISORY COMMITTEE
Board/Management Information Classification · 95% confidence The document is an announcement regarding the proposed election of directors and supervisors for the ninth session of the board and supervisory committee of Yankuang Energy Group Company Limited. It details nominations, resignations, and biographical information of candidates, and mentions the upcoming 2022 annual general meeting where these appointments will be considered and approved. The content focuses on changes in the company's board of directors and supervisory committee members, including service terms and remuneration. There is no financial data, earnings information, or report publication mentioned. The document is not a full annual report, audit report, or earnings release. It is not a proxy solicitation or voting results announcement but rather an announcement of board and management changes. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (15,000 characters) and detailed content support this classification with high confidence.
2023-03-24 English
2022 Environmental, Social and Governance Report
Regulatory Filings
2023-03-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2023-03-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2023-03-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.